|
|
|
|
By working with trial-naïve sites it is possible to not only expand patient-access to sites within their communities, but also increase enrollment and retention. Take a closer look at how the right kind of support enables inexperienced sites to enter the clinical trial space and outperform their more experienced counterparts, and how this can be done sustainably in order for them to continue to run clinical trials in their communities.
|
|
|
|
|
Learn how community and patient-centric site networks with decentralized clinical trial (DCT) capabilities work with a broad range of site types, empowering them to participate in every type of study and, in turn, provide lifesaving, critical care to all patient populations, especially those who are historically underserved and underrepresented in clinical trials.
|
|
|
|
|
A discussion between Dr. Graham Wylie, MRN Founder & Chair, and Adrienne Bryce, MRN VP of Strategy & Clinical Governance, explores how integrated DCT/hybrid trial design approaches — combining in-home care, supported community sites, and regulatory-approved technology — can make oncology research more flexible, inclusive, and sustainable for the long term.
|
|
|
|
|
While the hybrid/DCT Home Trial Support (HTS) solution offers a well-documented range of benefits for sponsors, sites, and patients alike, it also offers a myriad of hidden healthcare benefits. Examine how HTS enhances both patient & caregiver safety and wellbeing, while alleviating pressures on sites and generating greater ROI for sponsors.
|
|
|
|
|
|
|
|
September 16-17 | Philadelphia, PA
|
MRN is focused on bringing clinical trials to patients, no matter where they are. Meet with the MRN Team at the 15th annual DPharm conference, and learn how we can work with you to leverage our proven, existing in-home and at-site solutions to make your trial more inclusive and accessible while accelerating your trial timelines. Schedule a meeting time here.
|
|
|
|
|
